# SMOOTH - Blood Pressure Control in Diabetic/Obese Patients

> **NCT00239538** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 840 (actual)

## Conditions studied

- Hypertension
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** telmisartan combined with hydrochlorothiazide (80/12.5 mg)
- **DRUG:** valsartan combined with hydrochlorothiazide (160/12.5mg)

## Key facts

- **NCT ID:** NCT00239538
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 840 (ACTUAL)
- **Last updated:** 2013-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239538, "SMOOTH - Blood Pressure Control in Diabetic/Obese Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00239538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*